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Peptide Synthesis
General information
H-Ramage ChemMatrix® resin (0.53 mmol g -1 ) was obtained from PCAS-Biomatrix (Quebec, Canada) and H-Rink Amide ChemMatrix® resin (100-200 mesh, 0.59 mmol g -1 ) was obtained from Novabiochem (San Diego, CA). L-amino acids were obtained from Advanced Chemtech (Louisville, KY). Fmoc-threonine, serine, glutamic acid and tyrosine were t-butyl protected. Fmoc-tryptophan was used as both Boc protected and unprotected. Unnatural alkenyl amino acids were purchased from OKeanos (Beijing, China). All other solvents and reagents were obtained from Sigma-Aldrich. 1,2-dichloroethane (DCE) was dried overnight over activated molecular sieves and purged with Argon for 30 min prior to use. All other reagents were used as received.
Stapled peptide preparation
Solid-Phase peptide synthesis: The peptides were synthesised manually using solid phase and Fmoc chemistry at the 0.1 mmol scale using either H-Ramage-Chemmatrix resin (0.53 mmol g ). The dry resin was weighed out into a fritted reaction vessel and swelled with NMP before use. The Fmoc protecting group was removed by treatment with 20% piperidine in DMF and nitrogen gas bubbling (15 min). The Fmoc-protected amino acids (5 equiv.) were coupled using pre-activated (7 min) solutions of HATU (4.9 equiv.) and DIPEA (5 equiv.) in NMP (0.23 M) or DIC (5 equiv.) and HOAt (5 equiv.) in NMP (0.4-0.45 M). The coupling time was 90 min for all amino acids except for (S)-N-Fmoc-2-(4'-pentenyl)alanine and (R)-N-Fmoc-2-(7'-octenyl)alanine, which were preactivated and coupled (4 equiv.) for two hours. The amino acids immediately following the α,α-disubstituted amino acids were double coupled. Following deprotection of the final Fmoc group, the peptides were acetylated using a mixture of acetic anhydride:DIPEA:DMF (2:2:1) for 60 min. After each coupling, deprotection and acetylation reaction, the resin was thoroughly washed with NMP.
On-resin peptide metathesis and cleavage: Ring-closing metathesis of resin-bound, N-acetylated peptides was performed manually using a solution of Grubbs I catalyst (20 mol%, 5 mg mL -1 ) in dry 1,2-dichloroethane (DCE) at room temperature. The reaction was agitated by bubbling with argon gas (3 x 2 h treatments, with the addition of fresh catalyst solution at the start of each cycle). The reaction mixture was drained, the resin washed with DMSO:DMF (1:1, 1 x 2h), DCE (3 x 1 min) and MeOH (3 x 1 min) then dried under vacuum. Cleavage of the peptide from the resin was achieved using a TFA cocktail consisting TFA:triisopropylsilane:water (95:2.5:2.5, 8 mL) for 2 h followed by filtration and precipitation with S3 diethyl ether. The precipitate was collected by centrifugation, dried under a stream of argon and redissolved in a mixture of acetonitrile and water (1:1).
Acetic acid-mediated carboxylate hydrolysis:
To a solution of peptide in MeCN:H 2 O (3:1, 10 mg mL -1 ) was added acetic acid (0.2 mL) and the reaction mixture was stirred at room temperature overnight.
Peptide purification and analysis: The success of each synthesis was assessed first by HPLC and ESI-MS analysis of the crude reaction mixture. The peptides were purified by reverse-phase HPLC and the identities and purifies of the peptides were assessed by analytical HPLC (Figure S1 -S10), mass spectrometry (Table S1 ) and NMR spectrometry (Figure S11-S15).
Reverse-phase HPLC was performed using an Agilent 1260 Infinity system fitted with a Phenomenex ® analytical column (Jupiter C12, 4 μm, Proteo 90 Å, 150 x 4.6 mm). The eluents were 0.1% aqueous TFA and 0.1% TFA in acetonitrile. Mass spectra were acquired with a Waters 3100 Mass spectrometer. NMR spectra were recorded on a Bruker Ultrashield 600 MHz Plus or on Bruker 400 MHz with CryoProbe.
Chemical shifts are reported as  values in ppm relative to DMSO-d6. table S2 .
VIP82 early isomer unresolved
VIP82 late isomer unresolved (b) (a)
VIP116 early isomer unresolved
VIP116 late isomer unresolved (a) (b)
VIP115 early isomer unresolved
VIP116 early isomer unresolved
Analytical HPLC spectra
Linear sMTide-02
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Fig. S19 Accompanying analytical HPLC for entry 4, table S2. table S2 .
Linear sMTide-02 S12 
General silane reduction protocol:
Linear, N-acetylated peptide on resin (0.04-0.06 mmol) was weighed out into a fritted reaction vessel and swelled with degassed DCE before use. Ring-closing metathesis was performed as stated following the general protocol above. At the end of the final RCM cycle, the appropriate silane (5 equiv.) was directly added to the metathesis mixture and the hydrogenation carried out at the stated temperature Table S3 Tandem ring-closing metathesis/hydrogenation study. Percent conversion = product/(product + starting material) as determined by reverse phase HPLC ( Figure S26-S38) . a Solvent exchange required. b After each HPLC analysis, an additional aliquot of reagents was added to the reaction mixture. 
Adjusted retention time (t R ') calculations
All stapled peptides were re-evaluated using a fixed 35 min linear gradient (0.1 % aqueous TFA and 0.1% TFA in acetonitrile) from 5-95%, at a flow rate of 1 mL/min. The Agilent 1260 Infinity system was fitted with a Phenomenex ® analytical column (Jupiter C12, 4 μm, Proteo 90 Å, 150 x 4.6 mm). 
Circular dichroism (CD)
To facilitate buffer exchange, 5 µl of the 10 mM stock peptide, mixed with 45 µl of 100 % methanol, was dried in the SpeedVac concentrator (Thermo Scientific) for 2 hours. Buffer containing 1 mM Hepes pH 7.4 and 5 % methanol was used to reconstitute and dilute the peptide to 1 mM. The CD spectrum of the peptide was recorded from 300 to 190 nm at 25 ˚C, using the Chirascan-plus qCD machine (Applied Photophysics), and a quartz cuvette with a path length of 0.2 cm. Absorbance at 280 nm was used to determine the experimental concentration of the peptide. The CD spectrum was converted to mean residue ellipticity, before deconvoluting using the CDNN software (distributed by Applied Photophysics), to get an estimate of the secondary structure components of the peptide. All experiments were carried out in duplicates. 
Biological assays
T22 p53 reporter assay: T22 p53 β-galactosidase based reporter assay T22 cells, which were stably transfected with a p53 responsive β-galactosidase reporter, were seeded into 96-well plate at a cell density of 8000 cells per well. 1 Cells were also maintained in Dulbecco's Minimal Eagle Medium (DMEM) with 10% fetal bovine serum (FBS) and penicillin/streptomycin. The cells were incubated for 24 hours and then the media was removed and replaced with 90 µl of DMEM either with 2% FBS. Cells were
